Cairo, Egypt, September 2025 – Integrated Diagnostics Holdings (IDH) has announced the appointment of Abdelrahman Amin as Regional Head of Total Rewards. In this role, he will lead compensation and benefits strategies across the Group’s regional markets, aligning reward frameworks with organizational goals and driving employee engagement through innovative and scalable reward solutions.
Abdelrahman most recently worked at Coca-Cola HBC for nearly five years, where he advanced through multiple senior HR roles. As Senior Rewards Manager, he was responsible for designing and implementing compensation strategies that supported both business transformation and workforce motivation. Prior to that, as Compensation & Reporting Manager, he played a pivotal role in developing reporting frameworks and benefits structures, ensuring equity and competitiveness across markets.
Before Coca-Cola HBC, he served as Global Human Resources Manager at Swvl, a technology-driven mobility solutions company, where he contributed to global HR initiatives during a period of rapid international growth.
Earlier, Abdelrahman gained extensive HR and finance experience at Vodafone, holding roles including Senior HR Specialist, HR Reward Senior Specialist, Senior Payroll Accountant, Payroll Accountant, and Fixed Assets Accountant over more than four years. In these roles, he honed his expertise in payroll, compensation, benefits, and HR operations at scale.
He began his career with QNB Group as a Recovery Officer, where he developed strong foundations in financial analysis and employee relations. Across these roles, Abdelrahman has established himself as a trusted leader in total rewards, with deep expertise in compensation strategies, analytical frameworks, and benefits design.
About Integrated Diagnostics Holdings (IDH)
Integrated Diagnostics Holdings (IDH) is a leading consumer healthcare company in the Middle East and Africa, operating across Egypt, Jordan, Sudan, Nigeria, and Saudi Arabia. The Group’s core brands include Al Borg, Al Mokhtabar, Al Borg Scan, Biolab, Ultralab, and Echo Lab, offering more than 2,000 diagnostic tests with internationally recognized accreditations for quality and safety.
With over 538 branches as of June 2022, IDH operates under a Hub, Spoke, and Spike model that ensures scalability and efficiency, supporting both organic expansion and acquisitions. Listed on both the London Stock Exchange (LSE: IDHC) and the Egyptian Exchange (EGX: IDHC.CA), IDH continues to grow its presence across new Middle Eastern, African, and East Asian markets while upholding its reputation for quality healthcare diagnostics.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
